NCT06092268 2023-10-23
A Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patients With Advanced Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2 Unknown
Clinical Trials
8 trialsNCT06082570 2023-10-13
A Study to Observe and Evaluate the Safety and Efficacy of c610 Injection for Treatment of Advanced Solid Tumor Patients
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1/2 Unknown
NCT05862831 2023-05-17
Clinical Study of PM1003 in Phase I/IIa Treatment of Advanced Malignant Solid Tumors
Biotheus Inc.
Phase 1/2 Unknown
NCT05688605 2023-01-18
A Study of MRG003 in the Treatment of Patients With EGFR-positive Advanced or Metastatic Solid Tumors
Shanghai Miracogen Inc.
Phase 1/2 Unknown
NCT04450901 2022-12-05
Dose Escalation/Dose Expansion Study of YBL-006 in Patients With Advanced Solid Tumors
Y Biologics Inc.
Phase 1/2 Unknown
NCT05457517 2022-09-27
A Phase 1b/2 Study of YL-13027 Combined With Sintilimab in Patients With Advanced Solid Tumors
Shanghai YingLi Pharmaceutical Co. Ltd.
Phase 1/2 Unknown
NCT04699643 2021-01-07
FGFR4 Inhibitor EVER4010001 in Combination With PD-1 Inhibitor Pembrolizumab in Patients With Advanced Solid Tumors
EverNov Medicines (Zhuhai Hengqin) Co., Ltd
Phase 1/2 Unknown
NCT03439761 2018-03-16
An Open-label Phase I/II Clinical Trial of PT-112 Injection for Advanced Solid Tumors and Advanced Hepatocellular Carcinoma
SciClone Pharmaceuticals
Phase 1/2 Unknown